Repurposing FDA-approved drugs for SARSCoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction

{{article.zuoZheEn}}

PDF(840 KB)
PDF(840 KB)
Protein Cell ›› DOI: 10.1007/s13238-020-00803-w
LETTER

Repurposing FDA-approved drugs for SARSCoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Protein Cell, https://doi.org/10.1007/s13238-020-00803-w

References

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(840 KB)

Accesses

Citations

Detail

Sections
Recommended

/